Anti-cytokine therapy and plasma DNA in patients with rheumatoid arthritis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Rheumatology International

• Publication date

  2018-05-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00296-018-4055-8PMID 29796906
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis

  2017cited by this paper
• Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers

  2017cited by this paper
• Role of Mitochondrial DNA in Septic AKI via Toll-Like Receptor 9.

  2016cited by this paper
• Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.

  2016cited by this paper
• Impaired DNase1‐mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies

  2015cited by this paper
• Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments

  2015cited by this paper
• Decreased serum cell-free DNA levels in rheumatoid arthritis

  2015cited by this paper
• Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility

  2014cited by this paper
• Endocytosis‐free DNA sensing by cell surface TLR9 in neutrophils: Rapid defense with autoimmune risks

  2013cited by this paper
• Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps

  2013cited by this paper
• Prognostic utility and characterization of cell-free DNA in patients with severe sepsis

  2012cited by this paper
• Extracellular GC-rich DNA activates TLR9- and NF-kB-dependent signaling pathways in human adipose-derived mesenchymal stem cells (haMSCs)

  2012cited by this paper
• The Disease Activity Score and the EULAR response criteria.

  2009cited by this paper
• Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis: As Good as it Gets?

  2008cited by this paper
• Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis.

  2007cited by this paper

• Circulating cell-free DNA as a potential biomarker for prediction of disease activity and prognosis among Egyptian rheumatoid arthritis patients

  2025cites this paper
• Targeting age-related cell-free DNA for prevention, early diagnosis and treatment of rheumatoid arthritis.

  2025cites this paper
• Evaluation of the HumanMethylationEPIC v2.0 Bead Chip Using Low Quality and Quantity DNA Samples

  2025cites this paper
• TREX1 Activators: A Novel Therapeutic Strategy for Rheumatoid Arthritis Management via cfDNA Clearance.

  2025cites this paper
• Comprehensive analysis of eccDNA characteristics and associated genes expression in peripheral blood of ASLE and ISLE patients

  2025cites this paper
• Cell-free DNA: a metabolic byproduct with diagnostic and prognostic potential in rheumatic disorders

  2025cites this paper
• The Circulating Biomarkers League: Combining miRNAs with Cell-Free DNAs and Proteins

  2024cites this paper
• The Impact of Disease Severity on the Serum Levels of Significant Neutrophil Extracellular Trap (NET) Proteins in Patients with Psoriasis

  2024cites this paper
• Exploring the Role of Extrachromosomal Circular DNA in Human Diseases

  2024cites this paper
• Effects of exogenous deoxyribonuclease I in collagen antibody-induced arthritis

  2024cites this paper
• Plasma mtDNA as a possible contributor to and biomarker of inflammation in rheumatoid arthritis

  2024cites this paper
• Circulating cell-free DNA correlate to disease activity and treatment response of patients with radiographic axial spondyloarthritis

  2024cites this paper
• Circulating Cell-Free DNA in Inflammatory Bowel Disease: Liquid Biopsies with Mechanistic and Translational Implications

  2023cites this paper
• The methylome and cell-free DNA: current applications in medicine and pediatric disease

  2023cites this paper
• Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis.

  2023cites this paper
• Role of Liquid Biopsies in Rheumatoid Arthritis.

  2023cites this paper
• Metabolic Effects of Anti-TNF-α Treatment in Rheumatoid Arthritis

  2023cites this paper
• Extrachromosomal circular DNA (eccDNA): an emerging star in cancer

  2022cites this paper
• NETosis in Psoriatic Arthritis: Serum MPO–DNA Complex Level Correlates With Its Disease Activity

  2022cites this paper
• The dynamics of extracellular DNA associates with treatment response in patients with rheumatoid arthritis

  2022cites this paper
• Cell-Free DNA in the Pathogenesis and Therapy of Non-Infectious Inflammations and Tumors

  2022cites this paper
• Liquid Biopsy and Its Emerging Role in Rheumatology.

  2022cites this paper
• Extra Chromosomal DNA in different cancers: individual genome with important biological functions.

  2021cites this paper
• Circulating Free DNA and Its Emerging Role in Autoimmune Diseases

  2021cites this paper
• Cell-Free DNA in Rheumatoid Arthritis

  2021cites this paper
• A review of Liquid biopsy as a tool to assess Epigenetic, cfDNA and miRNA variability as Methotrexate response predictors in patients with Rheumatoid Arthritis.

  2021cites this paper
• Identification of Etanercept Responsive Biomarkers in Rheumatoid Arthritis

  2020cites this paper
• AB1331 URINE METABOLIC PROFILE IN RHEUMATOID ARTHRITIS DEVELOPMENT

  2019cites this paper
• AB1333 CELL-FREE DNA AND BIOLOGICAL TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS

  2019cites this paper
• Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases

  2019influential citation
• AB1330 SOLUBLE VASCULAR CELL ADHESION MOLECULE-1 AS AN INDEPENDENT MARKER FOR ENDOTHELIAL ACTIVATION IS ELEVATED IN ACTIVE RHEUMATIC DISEASES: A MULTIVARIATE ANALYSIS

  2019cites this paper